Pilot study of the use of Janus Kinase Inhibitor, Baricitinib, in the treatment of heritable interferonopathy Aicardi Goutières Syndrome (P3.323)Adeline Vanderver, Amy Waldman, Francesco Gavazzi et al.|Neurology|2018Cited by 2